The DOCTORS Act amends INA section 214(l) to require state agencies to report unused waivers of the J‑1 foreign‑residency requirement and directs the State Department to reallocate reported unused waivers as supplemental waivers to eligible state agencies. The reallocation is subject to a statutory cap (one‑third of the gap between available and distributed waivers), includes an annual notification cycle, and reserves 10% of supplemental waivers for positions serving medically underserved communities.
This bill matters to residency program directors, state health workforce offices, exchange‑visitor program administrators, and hospitals that place J‑1 physicians: it creates a predictable, federal mechanism to move unused waiver capacity to high‑use states, alters how states plan residency placements, and imposes new reporting and allocation rules that will influence where J‑1 physicians can remain in the U.S. after training.
At a Glance
What It Does
The law requires each State agency that received 212(e) waivers to report by September 30 each year how many waivers went unused in the fiscal year. The Secretary of State will total those unused waivers, calculate a cap equal to one‑third of the difference between available and distributed waivers, and reallocate supplemental waivers equally among eligible state agencies for use the following fiscal year.
Who It Affects
State health or workforce agencies that receive and use 212(e) waivers, the Department of State (which must administer reporting and reallocations), teaching hospitals and residency programs that sponsor J‑1 physicians, and facilities serving medically underserved communities that may receive placements under the 10% carve‑out.
Why It Matters
The bill changes how finite waiver slots move between jurisdictions rather than remaining idle, potentially increasing the number of J‑1 physicians who complete U.S. residencies without returning abroad. It also shifts some allocation power to the Secretary of State and establishes a statutory floor (eligible‑agency threshold) that favors states with consistently high waiver usage.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The DOCTORS Act creates an annual cycle for identifying and repurposing 212(e) waivers that state agencies received but did not use. Under the bill, every state agency that received a waiver during the fiscal year must report its unused count to the State Department by September 30.
The Department then aggregates those unused waivers and computes how many can be reallocated the following fiscal year.
The statute limits how many supplemental waivers the Department may distribute: it sets the cap at one‑third of the gap between the total number of waivers available in a fiscal year and the number actually distributed that year. Within that cap, the Department will reallocate waivers for equal distribution among eligible state agencies—those that used at least 30 waivers in the prior fiscal year.
The Department must notify eligible agencies by January 1 of the number and method of distribution for the supplemental waivers they will receive for the next fiscal year.The bill also requires that 10% of supplemental waivers distributed in any fiscal year be reserved for positions located in facilities that serve medically underserved communities, tying some reallocated capacity to federally defined shortage areas. Practically, that means some supplemental slots will be earmarked for placements in clinics or hospitals serving population groups designated under section 799B of the Public Health Service Act.By building reporting, a mathematical cap, an eligibility threshold, and a small targeted carve‑out into the waiver pipeline, the DOCTORS Act attempts to convert idle waiver capacity into additional residency opportunities in states and facilities that have historically absorbed large numbers of J‑1 physicians.
It leaves implementation details—such as the precise reporting form, timing alignment with residency matches, and how the Department treats partially used waivers—to administrative guidance.
The Five Things You Need to Know
State agencies must report the number of 212(e) waivers they did not use during the fiscal year to the Secretary of State by September 30 each year, starting 2026.
The Secretary of State will reallocate reported unused waivers as 'supplemental waivers' for the next fiscal year, distributing them equally among eligible state agencies.
The total supplemental waivers reallocated in a fiscal year cannot exceed one‑third of the difference between total waivers available and waivers distributed in that fiscal year.
The Secretary of State must notify eligible state agencies by January 1 each year of how many supplemental waivers they will receive and the distribution method.
Ten percent of supplemental waivers distributed in a fiscal year must be used to support positions in facilities serving medically underserved communities (per 42 U.S.C. 295p).
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Annual reporting of unused waivers by State agencies
This subsection requires each State agency that received any 212(e) waivers during the fiscal year to report, by September 30, how many of those waivers it did not use. The practical effect is to create a single annual data point that the Department of State will use to identify unused capacity. For state offices this imposes a new compliance task tied to the federal fiscal year and will likely require coordination with residency programs and sponsors to track which waivers converted into placements.
Calculation and cap for supplemental waivers
This provision directs the Secretary of State to total the reported unused waivers and reallocate them subject to a statutory ceiling: supplemental waivers are limited to one‑third of the difference between waivers available and waivers actually distributed in the fiscal year. That formula prevents wholesale redistribution of all unused waivers and ties reallocation volume to the overall utilization rate, effectively creating a predictable but constrained pool of reassignable slots.
Notification timing and equal distribution rule
The Department must notify eligible state agencies on January 1 about how many supplemental waivers they will receive and how distribution will work. The bill specifies equal distribution among eligible agencies; it does not permit need‑based weighting. This design simplifies allocation mechanics but could mismatch supply with local demand because the equality rule ignores state population, residency capacity, or shortage metrics.
10% carve‑out for medically underserved facilities
Ten percent of supplemental waivers in a given fiscal year are reserved for positions in one or more facilities serving patients in medically underserved communities, as defined by PHSA section 799B. That ties some redistributed capacity directly to federal definitions of shortage areas and signals policy intent to steer physicians into underserved settings, though the bill leaves placement mechanics—such as compliance checks or documentation of 'serving' status—to implementing guidance.
Eligibility threshold for receiving supplemental waivers
A state agency is eligible to receive supplemental waivers only if it used at least 30 waivers in the preceding fiscal year. This creates a clear numerical qualification that privileges high‑use states and excludes offices with smaller programs, concentrating reallocated slots among jurisdictions with established placement capacity.
This bill is one of many.
Codify tracks hundreds of bills on Immigration across all five countries.
Explore Immigration in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- High‑use State agencies (those that used ≥30 waivers): They gain access to supplemental waivers distributed equally among eligible states, increasing their ability to retain J‑1 physicians and expand residency placements.
- Teaching hospitals and residency programs in eligible states: Additional supplemental waivers can translate into more filled residency positions and a larger pipeline of physicians who may stay in the U.S. after training.
- Patients in medically underserved communities: The 10% carve‑out directs some supplemental slots to facilities serving shortage areas, which could improve physician availability in underserved clinics and hospitals.
Who Bears the Cost
- State health workforce agencies: They must implement annual reporting processes and coordinate waiver accounting, adding administrative workload and potential IT or personnel costs.
- States that underuse waivers: Jurisdictions that do not reach the 30‑waiver threshold will be ineligible for supplemental reallocations and may permanently lose potential placement capacity to higher‑use states.
- Department of State: The agency must build and run the reporting aggregation and reallocation system, prepare annual notifications, and develop guidance on distribution and underserved‑facility verification.
Key Issues
The Core Tension
The core dilemma is efficiency versus targeting: the bill aims to maximize the use of limited 212(e) waiver slots by moving unused capacity to states that historically absorb many J‑1 physicians, but its equal‑distribution rule, eligibility threshold, and modest reallocation cap may prioritize administrative simplicity and reward high‑use regions over directing resources to smaller or rural areas with acute needs—forcing a trade‑off between turning idle slots into placements and equitably addressing geographic physician shortages.
The bill leaves several operational ambiguities that matter for implementation. It does not define whether 'unused' means waivers not granted, not accepted by sponsors, or not converted into physician placements; that distinction affects reporting counts.
The equal distribution rule and the ≥30 waiver eligibility threshold create winners and losers among states but do not account for differences in residency pipeline capacity or rural needs, potentially sending supplemental waivers to states that can absorb them easily rather than to places with the greatest shortage.
Timing mismatches pose a practical risk. Reporting is due September 30, notifications go out January 1, and reallocations apply to the subsequent fiscal year—this sequence may not align cleanly with residency match cycles and hospital hiring timelines, limiting the usefulness of supplemental waivers in the immediate recruitment season.
Finally, the 1/3 cap on reallocation is formulaic but arbitrary; it confines the scale of reassignments and may leave substantial unused waiver capacity untapped even when demand exists elsewhere.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.